PEHL MICHAEL F. 4
4 · IMMUNOMEDICS INC · Filed Sep 18, 2018
Insider Transaction Report
Form 4
IMMUNOMEDICS INCIMMU
PEHL MICHAEL F.
DirectorPresident and CEO
Transactions
- Award
Stock Options (right to buy)
2018-09-14+81,800→ 81,800 totalExercise: $22.27From: 2019-09-14Exp: 2025-09-14→ Common Stock, par value $0.01 per share (81,800 underlying)
Footnotes (1)
- [F1]The reporting person was granted stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and on a quarterly basis thereafter over a three year period.